Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Buy
56
PBE Quote, Financials, Valuation and Earnings
Last price:
$67.47
Seasonality move
:
1.72%
Day range:
$67.01 - $67.85
52-week range:
$59.32 - $72.84
Dividend yield:
0.05%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
3.1K
Avg. volume:
6.8K
1-year change:
2.38%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingInvesco Biotechnology & Genome ETF has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Invesco Biotechnology & Genome ETF has an estimated downside of -- from its current price of $67.85.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $67.85.
Fair Value
-
According to the consensus of 0 analysts, Invesco Biotechnology & Genome ETF has -- downside to fair value with a price target of -- per share.
PBE vs. S&P 500
-
Over the past 5 trading days, Invesco Biotechnology & Genome ETF has overperformed the S&P 500 by 0.98% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Invesco Biotechnology & Genome ETF does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Invesco Biotechnology & Genome ETF has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Invesco Biotechnology & Genome ETF reported revenues of --.
Earnings Growth
-
Invesco Biotechnology & Genome ETF has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Invesco Biotechnology & Genome ETF reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-27 | 2023-12-27 | 2023-12-27 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-27 | 2021-12-27 | 2022-12-27 | 2023-12-27 | ||
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-27 | 2023-12-27 | 2023-12-27 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
PBE
Sector
Market Cap
--
--
Price % of 52-Week High
93.15%
--
Dividend Yield
0.05%
--
Shareholder Yield
--
--
1-Year Price Total Return
2.38%
--
Beta (5-Year)
0.819
--
Dividend yield:
0.05%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$67.59
200-day SMA
Buy
Level
$67.03
Bollinger Bands (100)
Sell
Level
67.89 - 70.93
Chaikin Money Flow
Buy
Level
12.1M
20-day SMA
Sell
Level
$69.15
Relative Strength Index (RSI14)
Sell
Level
45.02
ADX Line
Buy
Level
17.33
Williams %R
Neutral
Level
-54.4754
50-day SMA
Sell
Level
$69.09
MACD (12, 26)
Sell
Level
-0.59
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
902.4K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Stock Forecast FAQ
In the current month, PBE has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PBE average analyst price target in the past 3 months is --.
-
Where Will Invesco Biotechnology & Genome ETF Stock Be In 1 Year?
According to analysts, the consensus estimate is that Invesco Biotechnology & Genome ETF share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Invesco Biotechnology & Genome ETF?
Analysts are divided on their view about Invesco Biotechnology & Genome ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Invesco Biotechnology & Genome ETF is a Sell and believe this share price will rise from its current level to --.
-
What Is Invesco Biotechnology & Genome ETF's Price Target?
The price target for Invesco Biotechnology & Genome ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PBE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Invesco Biotechnology & Genome ETF is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of PBE?
You can purchase shares of Invesco Biotechnology & Genome ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Invesco Biotechnology & Genome ETF shares.
-
What Is The Invesco Biotechnology & Genome ETF Share Price Today?
Invesco Biotechnology & Genome ETF was last trading at $67.47 per share. This represents the most recent stock quote for Invesco Biotechnology & Genome ETF. Yesterday, Invesco Biotechnology & Genome ETF closed at $67.85 per share.
-
How To Buy Invesco Biotechnology & Genome ETF Stock Online?
In order to purchase Invesco Biotechnology & Genome ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 6.46% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 2.42% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 3.74% over the past day.
